USADA announced today that Camilo Ulloa, of Milwaukee, Wis., an athlete in the sport of cycling, has tested positive for multiple prohibited substances and accepted a four-year sanction for his anti-doping rule violation.
Ulloa, who is a Pro/Cat1 Colombian cyclist, was tested in-competition on June 25, 2016, as a part of USA Cycling’s RaceClean Program due to being among the top finishers in his event at the 2016 Tour of America’s Dairyland in Wisconsin. USA Cycling’s RaceClean Program works to fight doping at the elite and amateur levels of cycling. Elite athlete testing through the RaceClean program is funded by fees collected from trade teams, race directors, and elite athlete license surcharges.
Ulloa’s sample tested positive for the presence of Methylphenidate and its metabolite, Ritalinic Acid. In addition, the sample tested positive for an Anabolic Agent, and/or its metabolites, which was confirmed by Isotope Ratio Mass Spectrometry (IRMS) analysis. Every urine sample that USADA collects is scrutinized under an Athlete Biological Passport program that examines levels of multiple steroid biomarkers that can indicate doping. Samples that exhibit atypical qualities are then targeted for more sophisticated IRMS analyses, which can reveal the presence of synthetic, prohibited Anabolic Androgenic Steroids (AAS).
Methylphenidate is in the class of Stimulants and prohibited in-competition, while the use of any exogenous Anabolic Agent is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the Union Cycliste Internationale Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Ulloa’s four-year period of ineligibility began on August 8, 2016, the date he received a provisional suspension. In addition, Ulloa has been disqualified from all competitive results obtained on and subsequent to June 25, 2016, the date his positive sample was collected, including forfeiture of any medals, points, and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.